Literature DB >> 12855025

Serious consequences of a sore throat.

M G Clarke1, N J Kennedy, K Kennedy.   

Abstract

Lemierre's syndrome, caused by Fusobacterium necrophorum, is a potentially fatal sequelae of a sore throat characterised by septicaemia, internal jugular vein thrombophlebitis and metastatic abscesses. The Chief Medical Officer reported in February 2001 that the incidence is increasing. Two cases seen in one year, with different presentations, are reported. The first patient presented with sepsis, jaundice, hepatic abscesses and portal vein/superior mesenteric vein thrombosis, whilst the second presented with sepsis, sore throat and internal jugular vein thrombophlebitis. Both patients were treated with antibiotics and anticoagulants with a favourable outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12855025      PMCID: PMC1964399          DOI: 10.1308/003588403766274935

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  5 in total

Review 1.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

2.  Just a simple case of tonsillitis? Lemierre's Syndrome and thrombosis of the external jugular vein.

Authors:  Kh Hutson; Jc Fleming; Ja McGilligan
Journal:  J Surg Case Rep       Date:  2011-04-01

Review 3.  Fusobacterial liver abscess: a case report and review of the literature.

Authors:  Dilip Jayasimhan; Linus Wu; Paul Huggan
Journal:  BMC Infect Dis       Date:  2017-06-20       Impact factor: 3.090

4.  Fusobacterium necrophorum subsp. necrophorum Liver Abscess with Pylephlebitis: An Abdominal Variant of Lemierre's Syndrome.

Authors:  Natasa Radovanovic; Igor Dumic; Mladjen Veselinovic; Susanne Burger; Tamara Milovanovic; Charles W Nordstrom; Eric Niendorf; Poornima Ramanan
Journal:  Case Rep Infect Dis       Date:  2020-01-13

5.  A case of Lemierre syndrome.

Authors:  Ameen Alherabi
Journal:  Ann Saudi Med       Date:  2009 Jan-Feb       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.